Improvements in chronic myeloid leukemia (CML). chronic lymphocytic leukemia (CLL). and multiple myeloma (MM) treatment options have increased the 5-year survival rates for patients with these hematologic malignancies. In addition to cancer management. https://www.itsmajorlook.com/